News
-
-
-
PRESS RELEASE
Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 1st Interim Report
Alzchem Group AG announces acquisition of 20,156 shares in share buyback program. Detailed information available on company website -
PRESS RELEASE
Information regarding executed transactions within the framework of a share buyback programme (outside the liquidity agreement) from 3 August to 7 August 2026
Ayvens provides information on executed transactions for their share buyback programme outside liquidity agreement from 3 - 7 August 2026, in compliance with market regulations -
-
-
PRESS RELEASE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
French company Median Technologies discloses total voting rights and shares as of July 31, 2026, including details on preference shares and warrants. Innovating AI for cancer diagnostics and treatments -
-
-
![Logo of [UNKNOWN]](https://logos.symex.be/img/.jpg)
